This post is presented by our media partner Psychedelic News Wire
View the original article here.
The world is currently in the midst of a psychedelic renaissance that has seen dozens of research teams worldwide dedicate themselves to studying the potential mental health benefits of psychedelic-assisted treatments. Although psychedelic research is still a new field, initial studies and anecdotal reports from users indicate that hallucinogens have many significant mental health benefits.
Psychedelics have also enjoyed increased mainstream attention in recent years partly thanks to support from celebrities and public personalities. These celebrity testimonies, endorsements and, in some cases, investments in psychedelic research have significantly increased public interest in psychedelics at a time when the United States is in desperate need of safer and more effective mental health treatments.
National Football League’s (NFL) Aaron Rodgers is one of the latest celebrities to throw his support behind the growing psychedelic reform movement. The football star has long been an advocate for psychedelic reform, and he recently spoke at the Psychedelic Science 2023 convention in Denver, Colorado.
Rodgers said that previous experiences with ayahuasca, a psychedelic concoction that originated from South America, have allowed him to boost his performance on the field. According to Rodgers, ayahuasca played a significant role in him achieving 48 touchdowns and five interceptions and becoming MVP while he played with the Green Bay Packers.
Like several other psychedelics, ayahuasca has exhibited some mental health benefits in initial studies. Research has found that ayahuasca may have neuroprotective properties that allow it to stimulate the growth of neural cells and protect brain cells. Furthermore, studies show the psychedelic concoction may alleviate addiction disorders and depression while improving mindfulness and boosting mood.
Since the NFL has verified that its policy does not ban the use of ayahuasca, Rodgers was completely in the clear for indulging in the psychedelic. The quarterback may have been ridiculed in the past due to his preference for alternative medicines, but he believes ayahuasca helped him up his game.
This February, the quarterback went to a four-day darkness retreat to help him “get in a better headspace and have greater peace in his life.” Speaking at the convention, Rogers said that athletes in the NFL and other sports leagues have approached him for guidance on how to take psychedelics. He said that people now have the opportunity to dispel misconceptions about psychedelics by sharing their medical and spiritual journeys with each other.
The recent psychedelics event was held in Denver, one of the first regions in the country to pass propsychedelics policies. Legislators in several states are now working to legalize the therapeutic use of psychedelics such as ayahuasca, ketamine and psilocybin mushrooms.
With more events similar to the conference in Denver likely to be organized in the coming years, the pioneering work being done by startups such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is likely to be showcased more, resulting in growing public interest.
NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
This post was originally published by our media partner here.
